Key result
The BPMAP mobile application increased treatment adherence scores by an average of 5.9 points compared to usual care in patients with primary hypertension.
Why the study?
Hypertension self-management is significant given its rising incidence and disabilities, prompting evaluation of whether a mobile self-management application improves treatment adherence.
Does a mobile blood pressure management application improve adherence to treatment in patients with primary hypertension?
RCT (n=120)
Open-label
Permuted block randomization with a block size of four and 1:1 allocation ratio
No
Does a mobile blood pressure management application improve adherence to treatment in patients with primary hypertension?
Mean Difference: 5.9 (95% CI 5–6.7)
Absolute Event Rate: 65.1% vs 59.7%
A mobile health application providing education, reminders, and self-monitoring tools significantly improved medication adherence, diet, and physical activity in patients with primary hypertension.
Mobile health applications offer a scalable tool to improve medication and lifestyle compliance in primary hypertension; extends.
Background: Self-management of hypertension is of great significance given its increasing incidence and its associated disabilities. In view of the increased use of mobile health in medicine, the present study evaluated the effect of a self-management application on patient adherence to hypertension treatment. Methods: This clinical trial was performed on 120 hypertensive patients who were provided with a mobile intervention for 8 weeks and followed-up until the 24th week. Data on the primary outcome (adherence to treatment) and secondary outcomes (adherence to the DASH diet, regular monitoring of blood pressure, and physical activity) were collected using a questionnaire and a mobile application, respectively. The inter-group change difference over time was analyzed using repeated measures ANOVA (General Linear Model). Results: The treatment adherence score increased by an average of 5.9 (95% CI: 5.0-6.7) in the intervention group compared to the control group. Scores of 'adherence to the low-fat and low-salt diet plans' were 1.7 (95% CI: 1.3-2.1) and 1.5 (95% CI: 1.2-1.9), respectively. Moreover, moderate physical activity increased to 100.0 minutes (95% CI: 61.7-138.3) per week in the intervention group. Conclusion: The treatment and control of blood pressure require a multifaceted approach given its complexity and multifactorial nature. Considering the widespread use of smartphones, mHealth interventions can be effective in self-management and better patient adherence to treatments. Our results showed that this application can be used as a successful tool for hypertension self-management in patients attending public hospitals in developing countries. Trial registration: This study was registered in the Iran Randomized Clinical Trial Center under the number IRCT2015111712211N2 on January 1st 2016.
No takes yet. Share an insight, caveat, or question.
Bozorgi et al. (2020) conducted an RCT in Primary hypertension (n=120). BPMAP (Blood Pressure Management Application) vs. Usual care was evaluated on Adherence to antihypertensive medication (assessed with the 14-item Hill-Bone Scale) (MD 5.9, 95% CI 5.0-6.7). The BPMAP mobile application increased treatment adherence scores by an average of 5.9 points compared to usual care in patients with primary hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: